MiRNA marker for lung cancer disease risk assessment

The invention discloses a miRNA marker for lung cancer disease risk assessment. The miRNA marker comprises at least one of hsa-miR-4730, hsa-miR-125a, hsa-miR-3615 and hsa-miR-575. The AUC values of the miRNA marker for diagnosing the lung cancer disease risk are all 0.90 or above, and research resu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHANG LE, WU JIAWEI, CHEN YIYIN, ZHU PENGLIN, ZHAO DANDAN, GENG SHENG, ZHANG SUFANG, FAN HONGWEI, LI QI, LIN YUANYUAN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses a miRNA marker for lung cancer disease risk assessment. The miRNA marker comprises at least one of hsa-miR-4730, hsa-miR-125a, hsa-miR-3615 and hsa-miR-575. The AUC values of the miRNA marker for diagnosing the lung cancer disease risk are all 0.90 or above, and research results have great significance in lung cancer disease risk assessment. 本发明公开了一种用于肺癌患病风险评估的miRNA标志物,所述miRNA标志物包括hsa-miR-4730、hsa-miR-125a、hsa-miR-3615、hsa-miR-575中的至少一个。本发明的miRNA标志物诊断肺癌患病风险AUC值均为0.90以上,研究结果对于肺癌患病风险评估具有重要意义。